As nanotechnology improves by leaps and bounds, nanoformulations not only come into wide use in disease treatment and drug delivery but also are widely used for in vivo imaging. CD Formulation attaches great significance to the development and production of nanoformulation for in vivo imaging studies and has accumulated rich research experience in many years of practice. We are able to provide customers with personalized customized solutions and nanoformulation customization services for in vivo imaging studies.
Nanoformulations play an active role in in vivo imaging studies due to their ability to provide larger imaging payloads, higher sensitivity, multiplexing capabilities, and modular design. Using nanoformulation-based in vivo imaging techniques, we can observe deeply into the living body, which provides great opportunities for disease diagnosis and research. In the meantime, nanoformulations have become the key to producing high-resolution, high-contrast images and are widely used for precise disease diagnosis.
At the same time, due to the physical and chemical complexity of nanoformulations, we use advanced imaging techniques to visualize the metabolic behavior of systemically administered nanoformulations in situ. Thus, the use of in vivo imaging methods in the evaluation of nanoformulations can significantly improve the efficiency of nanoformulation development, rapidly advancing clinical translation and commercial applications of nanoformulations.
Fig.1 Non-invasive imaging modalities can provide real-time monitoring of NMs fate in vivo and facilitate their clinical translation. (Ruslan G. Tuguntaev, et al. 2022)
We take advantage of our advanced nanoformulation-based imaging techniques to offer anatomical, physiological, or molecular information about the in vivo systems to assist disease diagnosis.
In the MRI imaging, we provide a variety of information about the body's interior, including anatomical, physiological, and even molecular information, utilizing our contrast agents (e.g., paramagnetic (Gd3+) and superparamagnetic (Fe3O4) nanoparticles).
Through CT scanners, we utilize radioactive X-rays multiple times to acquire signals from different angles and process them with computers to reconstruct three-dimensional images.
We detect positron signals (gamma rays) emitted by radioactive isotopes or tracers by PET imaging to help with clinical diagnostics.
We detect different radioisotopes to visualize the system in the body by SPECT imaging to assist diagnostics.
In vivo optical imaging has the characteristics of non-invasive, highly sensitive, cost-effective, non-ionizing, and real-time imaging. Based on our professional knowledge and rich production experience, we fabricate plenty of best quality NIR fluorophores for in vivo imaging.
Fig.2 Incorporation of various contrast agents for multimodality imaging. (Jaehong Key, et al. 2014)
CD Formulation endeavors to gain a full understanding of the magnetic, optical, acoustic, and/or nuclear properties of nanomaterials and strives to pursue functionalized nanomaterial development.
According to the requirements of in vivo imaging (such as using magnetic resonance imaging, magnetic particle imaging, magneto-motive imaging, and electrical impedance imaging), we customize magnetic nanomaterials based on Gd3+, Mn2+, and iron-based materials, such as gadolinium oxides (Gd2O3), gadolinium phosphates (GdPO4), GdF3:CeFn3 nanomaterials, spherical MnO nanomaterials, hollow mesoporous silica MnO nanomaterials (HMnO@mSiO2), iron oxide and iron alloy-based nanomaterials, conductive nanomaterials such as titania and gold, etc.
Based on the performance of optical imaging, we design and produce fluorescent nanomaterials (such as quantum dots, qdots), carbon nanomaterials (such as carbon qdots), upconversion and persistent luminescent nanomaterials.
We are keen on exploring and researching the fabrication of neclear nanomaterials for imaging, such as radioactive nanomaterials, chelated nanomaterials and intrinsically labeled nanomaterials.
Our R&D center has also developed various nanobubbles, silica nanoparticles, and nanotubes for ultrasound imaging.
To advance and optimize in vivo imaging techniques, we design and synthesize varieties of adaptable nanomaterials, including lipid nanoparticles, polymeric nanoparticles, liposomes, polymeric micelles, silicon-based nanomaterials, etc.
Fig.3 Nanomaterials for in vivo imaging. (Bryan Ronain Smith, et al. 2017)
Nanoformulations for in vivo imaging studies can provide important information for disease diagnosis through various in vivo imaging methods. At our multiple nanotechnology platforms, CD Formulation is committed to designing and developing various nanomaterials for in vivo imaging, meeting customers' different needs, and promoting the rapid development of disease diagnostic technology.
Technology: Novel nanomedicines based on advanced optical imaging technology
Journal: Advanced Drug Delivery Reviews
IF: 15.2
Published: 2024
Results:
The authors use advanced optical imaging techniques for the rational design of nanomedicines and discuss in detail how to integrate advanced optical microscopy into different steps of the nanoparticle development workflow, namely by optimizing image acquisition, using machine learning (ML) to power microscopy, and image processing to help rationally design future nanomedicines. At the same time, the authors simplify the nanoparticle discovery workflow to find suitable or promising nanoparticle candidates for a given target diseased cell.
Fig.4 Advanced optical imaging for the rational design of nanomedicines. (Ana Ortiz-Perez, et al. 2024)
In vivo imaging technology can not only assist in the rational design of nanoformulations but also has great application potential in disease diagnosis. CD Formulation has researched various nanoformulations for in vivo imaging studies, based on lipid nanoparticles, liposomes, polymeric nanoparticles, metal and inorganic nanoparticles, natural nanoparticles, etc. If you are interested in our nanoformulation for in vivo imaging studies, please contact us.
References